A phase II safety and efficacy study of bavituximab plus paclitaxel and carboplatin in patients with locally advanced or metastatic breast cancer.
Phase of Trial: Phase II
Latest Information Update: 22 Nov 2011
At a glance
- Drugs Bavituximab; Carboplatin; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 22 Nov 2011 Results have been presented in a Peregrine Pharmaceuticals media release.
- 23 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Mar 2011 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.